Validation of Analytical Method LC MS/MS for Determination Isoniazid in Rats Serum

Andi Suhendi(1*), Abdul Rohman(2), Djoko Wahyono(3), Arief Nurrochmad(4), Tasya Faradillah Manggo(5)

(1) Universitas Muhammadiyah Surakarta
(2) Pharmaceutical Chemistry Department, Faculty of Pharmacy, Universitas Gadjah Mada, Sekip, Sleman, Indonesia
(3) Pharmacology and Clinical Pharmacy Department, Faculty of Pharmacy, Universitas Gadjah Mada
(4) Pharmacology and Clinical Pharmacy Department, Faculty of Pharmacy, Universitas Gadjah Mada
(5) Pharmaceutical Chemistry Department, Faculty of Pharmacy, Universitas Muhammadiyah Surakarta
(*) Corresponding Author

Abstract

Determination of isoniazid concentration for therapeutic drug monitoring must produce valid values, so validation of the analytical method of LC-MS/MS needs to be carried out. This research aims to obtain valid method of LCMS/MS in order to determination isoniazid in rats serum. Sample preparation was carried out using the liquid-liquid extraction method using acetonitrile and methanol (2:1). The chromatography system was developed with a C18 column (ACQUITY UPLC® HSS T3 1.8 µm, 2.1 × 100 mm), the mobile phase was 70% acetonitrile with 0.1% formic acid (A), water with 0.1% formic acid (B), as well as methanol (C) with a flow rate of 0.3 mL/min, with gradient elution, detection in ESI+ mode with multiple reaction monitoring (MRM) at the transition 138 m/z → 121 m/z. The research results showed that the method was accurate with a % recovery of 96 - 113% and an RSD of 2.4 ± 0.9%. The precision value was obtained with an average RSD of 3.7 ± 2.4% for intra-day and 4.1 ± 2.3% for inter-day. Linearity showed good results with a correlation coefficient of 0.9956 in tests with 5 different concentrations. The LOQ and LOD values obtained from the linear regression equation were 0.1987 µg/mL and 0.0656 µg/mL respectively. The results showed that the LC-M/MS method was valid for determining isoniazid levels in rat serum

Keywords

validation, LCMS/MS, isoniazid, Multiple Reaction Monitoring (MRM), rats serum

Full Text:

PDF

References

Alsultan, A., Peloquin, C.A., 2014. Therapeutic Drug Monitoring in the Treatment of Tuberculosis: An Update. Drugs 74, 839–854. https://doi.org/10.1007/s40265-014-0222-8

Babalik, A., Mannix, S., Francis, D., Menzies, D., 2011. Therapeutic Drug Monitoring in the Treatment of Active Tuberculosis. Can. Respir. J. 18, 225–229. https://doi.org/10.1155/2011/307150

Banerjee, S., Mazumdar, S., 2012. Electrospray ionization mass spectrometry: a technique to access the information beyond the molecular weight of the analyte. Int. J. Anal. Chem. 2012, 282574. https://doi.org/10.1155/2012/282574

Bhagat, R., Saudagar, R.B., 2019. A Review on Analytical method Development and Validation. J. Drug Deliv. Ther. 9, 1064–1067. https://doi.org/10.22270/jddt.v9i3-s.2957

Chegou, N.N., Hoek, K.G.P., Kriel, M., Warren, R.M., Victor, T.C., Walzl, G., 2011. Tuberculosis assays: past, present and future. Expert Rev. Anti Infect. Ther. 9, 457–469. https://doi.org/10.1586/eri.11.23

Daher, A., Pitta, L., Santos, T., Barreira, D., Pinto, D., 2015. Using a single tablet daily to treat latent tuberculosis infection in Brazil: Bioequivalence of two different isoniazid formulations (300 mg and 100 mg) demonstrated by a sensitive and rapid high-performance liquid chromatography-tandem mass spectrometry . Mem. Inst. Oswaldo Cruz 110, 543–550. https://doi.org/10.1590/0074-02760140458

EMA, 2022. ICH guideline M10 on bioanalytical method validation and study sample analysis.

FDA, 2018. Bioanalytical Method Validation Guidance for Industry.

Felipe, G., Regina, H., Salgado, N., Leandro, J., 2017. Isoniazid : A Review of Characteristics , Properties and Analytical Methods. Crit. Rev. Anal. Chem. 47, 298–308. https://doi.org/10.1080/10408347.2017.1281098

Hansen, F., Øiestad, E.L., Pedersen-Bjergaard, S., 2020. Bioanalysis of pharmaceuticals using liquid-phase microextraction combined with liquid chromatography–mass spectrometry. J. Pharm. Biomed. Anal. 189, 113446. https://doi.org/10.1016/j.jpba.2020.113446

Harmita, K., Harahap, Y., Supandi, 2019. Liquid Chromatography-Thandem Mass Spectrometry (LC-MS/MS). ISFI Penerbit, Jakarta.

Hee, K.H., Seo, J.J., Lee, L.S., 2015. Development and validation of liquid chromatography tandem mass spectrometry method for simultaneous quantification of first line tuberculosis drugs and metabolites in human plasma and its application in c. J. Pharm. Biomed. Anal. 102, 253–260. https://doi.org/10.1016/j.jpba.2014.09.019

Heysell, S.K., Moore, J.L., Keller, S.J., Houpt, E.R., 2010. Therapeutic Drug Monitoring for Slow Response to Tuberculosis Treatment in a State Control Program, Virginia, USA. Emerg. Infect. Dis. 16, 1546–1553. https://doi.org/10.3201/eid1610.100374

Jiang, Z., Huang, L., Zhang, L., Yu, Q., Lin, Y., Fei, H., Shen, H., Huang, H., 2022. A Simple and Sensitive UPLC–UV Method for Simultaneous Determination of Isoniazid, Pyrazinamide, and Rifampicin in Human Plasma and Its Application in Therapeutic Drug Monitoring. Front. Mol. Biosci. 9. https://doi.org/10.3389/fmolb.2022.873311

Kafeenah, H.I.S., Osman, R., Bakar, N.K.A., 2019. Effect of Mobile Phase pH on the Electrospray Ionization Efficiency and Qualitative Analysis of Pharmaceuticals in ESI + LC-MS/MS. J. Chromatogr. Sci. 57, 847–854. https://doi.org/10.1093/chromsci/bmz061

Kay, R., Barton, C., Ratcliffe, L., Matharoo-Ball, B., Brown, P., Roberts, J., Teale, P., Creaser, C., 2008. Enrichment of low molecular weight serum proteins using acetonitrile precipitation for mass spectrometry based proteomic analysis. Rapid Commun. Mass Spectrom. RCM 22, 3255–3260. https://doi.org/10.1002/rcm.3729

Kumar, L.M.S., Azeemuddin, M.M., Routhu, K.C., Priya, K., Babu, U.V., Pai, S.R., 2023. A validated LC-MS/MS method for simultaneous quantification of antitubercular drugs in rat plasma and its application for a pharmacokinetic interaction study with Immusante®. J. Appl. Pharm. Sci. 13, 151–158. https://doi.org/10.7324/JAPS.2023.118956

Lei, Q., Wang, Hao, Zhao, Y., Dang, L., Zhu, C., Lv, X., Wang, Hui, Zhou, J., 2019. Determinants of serum concentration of first-line anti-tuberculosis drugs from China. Medicine (Baltimore) 98, e17523. https://doi.org/10.1097/MD.0000000000017523

Liu, P., Fu, Z., Jiang, J., Yuan, L., Lin, Z., 2013. Determination of isoniazid concentration in rabbit vertebrae by isotope tracing technique in conjunction with HPLC. Biomed. Chromatogr. 27, 1150–1156. https://doi.org/10.1002/bmc.2920

Luyen, L.T., Hung, T.M., Huyen, L.T., Tuan, L.A., Huong, D.T.L., Duc, H.V., Tung, B.T., 2018. Simultaneous Determination of Pyrazinamide, Rifampicin, Ethambutol, Isoniazid and Acetyl Isoniazid in Human Plasma by LC-MS/MS Method. J. Appl. Pharm. Sci. 8, 061–073. https://doi.org/10.7324/JAPS.2018.8910

Pasipanodya, J.G., McIlleron, H., Burger, A., Wash, P.A., Smith, P., Gumbo, T., 2013. Serum Drug Concentrations Predictive of Pulmonary Tuberculosis Outcomes. J. Infect. Dis. 208, 1464–1473. https://doi.org/10.1093/infdis/jit352

Pitt, J.J., 2009. Principles and applications of liquid chromatography-mass spectrometry in clinical biochemistry. Clin. Biochem. Rev. 30, 19–34. https://pubmed.ncbi.nlm.nih.gov/19224008

Pouplin, T., Bang, N.D., Toi, P.V., Phuong, P.N., Dung, N.H., Duong, T.N., Caws, M., Thwaites, G.E., Tarning, J., Day, J.N., 2016. Naïve-pooled pharmacokinetic analysis of pyrazinamide, isoniazid and rifampicin in plasma and cerebrospinal fluid of Vietnamese children with tuberculous meningitis. BMC Infect. Dis. 16, 144. https://doi.org/10.1186/s12879-016-1470-x

Prahl, J.B., Johansen, I.S., Cohen, A.S., Frimodt-Møller, N., Andersen, Å.B., 2014. Clinical significance of 2 h plasma concentrations of first-line anti-tuberculosis drugs: a prospective observational study. J. Antimicrob. Chemother. 69, 2841–2847. https://doi.org/10.1093/jac/dku210

Pratima, N.A., Gadikar, R., 2018. Liquid Chromatography-Mass Spectrometry and Its Applications: A Brief Review. Arch. Org. Inorg. Chem. Sci. 1, 001–009. http://dx.doi.org/10.32474/AOICS.2018.01.000103

Vyas, A.K.J., Mishra, S.B., Patel, A.B., Patel, N.K., Shah, S.R., Sheth, D.B., 2022. A Brief Review on Liquid Chromatography- Mass Spectrometry/LCMS and its Application. Asian J. Pharm. Anal. 12, 203–210. https://doi.org/10.52711/2231-5675.2022.00034

WHO, World Health Organization., 2023. Global Tuberculosis Report 2023. WHO.

Xing, Y., Yin, L., Le, X., Chen, J., Zhang, Lin, Li, Y., Lu, H., Zhang, Lijun, 2021. Simultaneous determination of first-line anti-tuberculosis drugs and one metabolite of isoniazid by liquid chromatography/tandem mass spectrometry in patients with human immunodeficiency virus-tuberculosis coinfection. Heliyon 7, 1–11. https://doi.org/10.1016/j.heliyon.2021.e07532

Zheng, Y., Xu, N., Hu, X., Zhang, Q., Liu, Y., Zhao, Q., 2020. Development and Application of a LC-MS/MS Method for Simultaneous Quantification of Four First-Line Antituberculosis Drugs in Human Serum. J. Anal. Methods Chem. 2020, 1–10. https://doi.org/10.1155/2020/8838219

DOI: 10.23917/pharmacon.v20i2.23293

Article Metrics

Abstract view(s): 190 time(s)
PDF: 389 time(s)

Refbacks

  • There are currently no refbacks.